Validation of the Cutaneous Dermatomyositis Disease Area and Severity Index (CDASI): characterizing disease severity and assessing responsiveness to clinical change

BACKGROUND: The Cutaneous Dermatomyositis Disease Area and Severity Index (CDASI) was developed for use in clinical trials and longitudinal patient assessment. OBJECTIVES: To characterize disease severity using the CDASI and assess responsiveness of this instrument to clinically meaningful changes i...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Br J Dermatol
Päätekijät: Anyanwu, C.O., Fiorentino, D., Chung, L., Dzuong, C., Wang, Y., Okawa, J., Carr, K., Propert, K.J., Werth, V.P.
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: 2015
Aiheet:
Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC4878996/
https://ncbi.nlm.nih.gov/pubmed/25994337
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bjd.13915
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia